Trump signs order to separate childhood MMR vaccine, prompting political backlash
President Trump issued an executive order directing the Health Department to develop separate measles, mumps and rubella shots, a move welcomed by some vaccine-skeptical voters and criticized by Democrats ahead of the midterm elections.
President Donald Trump signed an executive order on Monday directing the U.S. Department of Health and Human Services to explore the development of separate measles, mumps and rubella (MMR) vaccines for children, rather than the combined shot currently used in the United States. The order reflects the president’s long-standing call for a more flexible childhood immunization schedule.
Supporters of the measure, including 28-year-old activist Jayme Franklin, said the change could appeal to voters who favor greater parental control over vaccine timing. Franklin, who appeared with the president at a briefing, described the action as a win for “MAHA” (Make America Healthy Again) supporters.
Democratic groups responded by framing the order as a politicized effort to undermine science-based health policy. Shaughnessy Naughton, president of the political action committee 314 Action, said the organization would emphasize the need for “science-based medical advice” and accountability in Washington. Democratic candidates such as Rep. Richard Pan of California and Senate candidate Annie Andrews of South Carolina cited the American Medical Association’s criticism of the president’s vaccine statements and urged voters to elect officials who support scientific consensus.
Public health experts warned that separating the MMR vaccine could leave children vulnerable to infection while awaiting subsequent doses, noting that the combined shot is designed to provide timely protection. Polling data from the Kaiser Family Foundation indicate that only a small fraction of voters—about 10% of those aligned with the MAHA movement—rank vaccine policy as a top priority, with cost-of-care and food-safety issues ranking higher.
The White House, speaking on condition of anonymity, described the order as a continuation of a long-standing presidential priority and said other health initiatives, including efforts to increase food-label transparency, lower drug prices and combat health-program fraud, remain underway.
Political analysts noted that while the order may energize a niche segment of the electorate, broader voter concerns this fall are likely to focus on affordability and the economy rather than vaccine scheduling.